7 Firms Guide GSK Spin-Off Haleon In London Listing
By Ashish Sareen ( July 18, 2022, 7:20 PM BST) -- Haleon PLC debuted Monday as a standalone company worth £30.5 billion ($36.4 billion) on the London Stock Exchange after completing its de-merger from the U.K. drugmaker GlaxoSmithKline PLC....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.